Charles Cho
Affiliations: | 1996- | University of California, Berkeley, Berkeley, CA, United States |
Google:
"Charles Cho"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li J, Canham SM, Wu H, et al. (2023) Activation of human STING by a molecular glue-like compound. Nature Chemical Biology |
| Brown JW, Cho CJ, Mills JC. (2021) Paligenosis: Cellular Remodeling During Tissue Repair. Annual Review of Physiology |
| Miao ZF, Cho CJ, Wang ZN, et al. (2020) Autophagy repurposes cells during paligenosis. Autophagy. 1-2 |
| Deng W, Desbien AL, Gauthier KS, et al. (2020) Abstract PR09: ADU-S100 (MIW815) synergizes with checkpoint blockade to elicit an antitumor CD8+ T-cell response to control distal tumors Cancer Immunology Research. 8 |
| Sivick KE, Desbien AL, Glickman LH, et al. (2019) Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 29: 785-789 |
| Sivick KE, Desbien AL, Glickman LH, et al. (2018) Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 25: 3074-3085.e5 |
| Cho CJ, Ahn JY, Jung HY, et al. (2016) The incidence and locational predilection of metachronous tumors after endoscopic resection of high-grade dysplasia and early gastric cancer. Surgical Endoscopy |
| McWhirter SM, Glickman LH, Desbien T, et al. (2016) Abstract B020: STING activation in the tumor microenvironment using a synthetic human STING-activating cyclic dinucleotide induces potent antitumor immunity Cancer Immunology Research. 4 |
| Glickman LH, Corrales L, Kanne DB, et al. (2016) Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity Cancer Research. 76 |
| Glickman LH, Kanne DB, Kasibhatla S, et al. (2016) Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity Cancer Research. 76: 1445-1445 |